NOVEL RESVERATROL POLYMERIZATION COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
申请人:Kishi Akinobu
公开号:US20140288334A1
公开(公告)日:2014-09-25
This invention relates to a resveratrol polymerization compound represented by Formula (1) (in which, in Formula (1), R
1
and R
2
represent —OH or Formula (2) and R
1
and R
2
are not the same) or a pharmaceutically acceptable salt thereof and an anticancer agent, an anticancer agent for oral cancer, an antioxidant, an antibacterial agent, a lipase inhibitor, an antiobesity agent, a therapeutic agent for skin diseases, a food, a pharmaceutical agent, a quasi drug, or a cosmetic containing one or more compounds selected from the group consisting of the resveratrol polymerization compound and the pharmaceutically acceptable salt thereof.
本发明涉及一种由公式(1)表示的白藜芦醇聚合物化合物(其中,在公式(1)中,R1和R2表示-OH或公式(2),且R1和R2不相同)或其药学上可接受的盐及其抗癌剂,口腔癌抗癌剂,抗氧化剂,抗菌剂,脂肪酶抑制剂,抗肥胖剂,皮肤疾病治疗剂,食品,药品,准药品或化妆品,其中包含从由白藜芦醇聚合物化合物和其药学上可接受的盐组成的群体中选择一个或多个化合物。